Patents for A61P 23 - Anaesthetics (4,141)
11/2000
11/23/2000WO2000069471A1 Enhanced transdermal anesthesia of local anesthetic agents
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000CA2373681A1 Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
11/23/2000CA2372919A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
11/22/2000EP1052975A1 Propofol composition containing sulfite
11/14/2000US6147122 Oil in water emulsion used for injection with antimicrobial growth agent; prevents growth of escherchia, candida, pseudomonas, and staphylococcus
11/09/2000WO2000066614A1 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000CA2372342A1 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049469A1 Biodegradable polymer matrices for sustained delivery of anesthetics
11/02/2000EP1047732A1 Color shifting film glitter
11/02/2000EP1047663A1 A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL- 2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE
11/01/2000CN1057918C New matrix magnetic therapeutic anesthesia analgesic paste
10/2000
10/31/2000US6140374 Propofol composition
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6139866 Tape formulation for percutaneous administration containing fentanyi
10/26/2000WO2000062740A2 Skin care compositions containing combination of skin care actives
10/26/2000CA2371399A1 Skin care compositions containing combination of skin care actives
10/25/2000EP1045826A1 Process for the preparation of isopropyl-methyl- 2-(3-n-propoxyphenoxy)ethyl]amine
10/24/2000US6136805 Quinoxaline dione derivatives, their production and their use in medicaments
10/19/2000WO2000061573A1 Novel benzodioxinones and method for obtaining same
10/19/2000WO2000061231A2 Medical use
10/19/2000WO2000061152A1 Management of pain after joint surgery
10/19/2000DE19915602A1 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-4-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000CA2369301A1 Management of pain after joint surgery
10/18/2000EP1043978A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
10/18/2000CN1270163A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/12/2000WO2000059851A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059472A1 Propofol compositions containing preservative additives
10/12/2000WO2000059471A1 Propofol formulation with enhanced microbial characteristics
10/12/2000CA2368083A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2366799A1 Propofol compositions containing preservative additives
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1043306A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/07/2000CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
10/05/2000WO2000057877A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/04/2000EP1040822A1 Extensible Mask with an adhesive matrix which is at least stretchable when wetted
10/03/2000US6126956 Subcutaneous implant
09/2000
09/27/2000CN1268051A Clear, injectable formulation of an anesthetic compound
09/20/2000CN1267219A Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
09/19/2000US6121375 Gels formed by the interaction of poly(aldehyde) with various substances
09/13/2000EP1033970A1 Novel formulation for use in pain management
09/12/2000US6117867 In medicine and veterinary medicine
09/12/2000CA2212794C Oil in water emulsions containing propofol and edetate
09/08/2000WO2000051981A1 Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics
09/06/2000EP1032390A1 Anaesthetic formulation
09/06/2000EP1032377A1 Substituted 2-aminoacetamides and the use thereof
09/06/2000EP1032368A1 Iontophoretic devices comprising piperidin derivatives
08/2000
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/29/2000US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents
08/29/2000US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics
08/24/2000WO2000048572A1 Phosphocholine linked prodrug derivatives
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/16/2000EP1027887A2 Matrix controlled release device
08/10/2000WO2000045832A2 Regulation of anaesthesia
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2360124A1 Regulation of anaesthesia
08/09/2000EP1025845A2 Hydromorphone tablets
08/08/2000US6100302 Propofol formulation with enhanced microbial characteristics
08/08/2000CA2056653C Preparation for transdermal drug administration
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000021520A3 Opioid analgesic
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
07/2000
07/27/2000WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/06/2000WO2000038684A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain
07/06/2000WO2000038678A1 Composition used as medicine and use of same for obtaining a medicine for anaesthesia, in particular analgesic medicine
07/06/2000CA2358067A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain
07/05/2000EP1014946A1 Sustained-release liposomal anesthetic compositions
07/05/2000CN1258502A Anaesthetic
06/2000
06/29/2000WO2000037047A1 Composition set and kit for use in intraocular surgery
06/28/2000EP1011743A1 Loading and release of water-insoluble drugs
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP1011636A1 New foam-forming pharmaceutical composition
06/27/2000CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments
06/21/2000EP1009524A1 Improvements in or relating to capsules
06/21/2000EP1009390A1 Prolonged anesthesia in joints and body spaces
06/21/2000CN1257483A Substituted isoquinolines as ultra short acting neuromuscular blockers
06/20/2000CA2215659C Morphinan hydroxamic acid compounds
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/02/2000WO2000030615A1 Method of preparing stable suspensions of insoluble microparticles
05/2000
05/31/2000DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs
05/31/2000CN1255065A Medicinal preparation containing lipophilicity inert gas
05/30/2000US6069155 Presurgery anesthetising humans
05/23/2000US6066676 Pharmaceutical composition and methods for using it
05/18/2000WO2000027407A1 Injectable anesthetic containing microparticles
05/18/2000WO2000027406A1 Injectable anesthetic containing a hydrophilic phase
05/18/2000WO2000027369A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
05/17/2000EP0999840A1 Use of draflazine-analogues for treating pain
05/17/2000EP0999839A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
05/11/2000WO2000025785A1 Plastics container containing stabilised drug formulations
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42